Indeed, a previous study demonstrated that NIBR189 blocks migration of CD4+ T cells collected from patients with MS in a transwell assay (Clottu et al., 2017) but that study did not investigate migration towards and attachment to the BBB, which are of key importance in the pathophysiology of MS. Here, CD4 is linked to myeloid sarcoma.